Nektar Therapeutics
NKTR
NKTR
148 hedge funds and large institutions have $820M invested in Nektar Therapeutics in 2025 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 42 increasing their positions, 25 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
38% more funds holding
Funds holding: 107 → 148 (+41)
14% more ownership
Funds ownership: 61.77% → 75.77% (+14%)
37% less call options, than puts
Call options by funds: $47.7M | Put options by funds: $75.6M
Holders
148
Holding in Top 10
4
Calls
$47.7M
Puts
$75.6M
Top Buyers
| 1 | +$72.6M | |
| 2 | +$48.8M | |
| 3 | +$45M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$40M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$20.5M |
Top Sellers
| 1 | -$22.4M | |
| 2 | -$16.6M | |
| 3 | -$11.6M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$11.1M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$7.58M |
